A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if 60 mg of duloxetine given once a day by mouth for
8 weeks to patients diagnosed with major depressive disorder, who also report associated
painful physical symptoms, is better than placebo when treating depression and its associated
painful symptoms.